Literature DB >> 11757580

Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease).

A S Wierzbicki1, G F Watt, J Lynas, A F Winder, R Wray.   

Abstract

Mixed hyperlipidaemia is a common finding in glycogen storage disease type Ia (GSD Ia). Although cross-sectional studies have demonstrated increases in intermediate-density lipoproteins (IDLs) and reductions in lipoprotein lipase activity, no studies have investigated the dynamics of apolipoprotein B-100 (apo B) metabolism in GSD Ia. This study investigated apoB turnover in GSD Ia using an exogenous labelling method in one sib from a kinship with established GSD Ia. The study demonstrated normal hepatic secretion of very low-density lipoprotein (VLDL), but hypocatabolism of VLDL, probably due to lack of lipoprotein lipase activity. The production rate of IDL was slightly increased, but the turnover rate of low-density lipoprotein was normal. The findings suggest that, as well as a corn starch diet and dietary fat restriction, treatment of severe mixed hyperlipidaemia in GSD Ia and its attendant risk of pancreatitis should possibly involve fibrates that activate lipoprotein lipase and may enhance the clearance of IDL, rather than omega-3 fatty acids, which principally suppress hepatic secretion of VLDL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757580     DOI: 10.1023/a:1012407609063

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.

Authors:  R R HOWELL; D M ASHTON; J B WYNGAARDEN
Journal:  Pediatrics       Date:  1962-04       Impact factor: 7.124

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

Review 3.  Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

Authors:  M A Austin; K L Edwards
Journal:  Curr Opin Lipidol       Date:  1996-06       Impact factor: 4.776

4.  The hyperlipidemia in glycogen storage disease.

Authors:  S Jakovcic; A K Khachadurian; D Y Hsia
Journal:  J Lab Clin Med       Date:  1966-11

5.  Value of the glucagon test in screening for hepatic glycogen storage disease.

Authors:  D B Dunger; J V Leonard
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

6.  Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding.

Authors:  E Levy; L A Thibault; C C Roy; M Bendayan; G Lepage; J Letarte
Journal:  J Lipid Res       Date:  1988-02       Impact factor: 5.922

7.  Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.

Authors:  T Demant; A Gaw; G F Watts; P Durrington; B Buckley; C W Imrie; C Wilson; C J Packard; J Shepherd
Journal:  J Lipid Res       Date:  1993-01       Impact factor: 5.922

8.  Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.

Authors:  E R Christ; M H Cummings; E Albany; A M Umpleby; P J Lumb; A S Wierzbicki; R P Naoumova; M A Boroujerdi; P H Sönksen; D L Russell-Jones
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

9.  Serum lipoproteins of patients with glycogen storage disease.

Authors:  E L Rosenfeld; I V Chibisov; I M Karmansky; V A Tabolin; L V Chistova; A F Leontiev
Journal:  Clin Chim Acta       Date:  1980-03-14       Impact factor: 3.786

10.  Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.

Authors:  E Levy; L Thibault; J Turgeon; C C Roy; C Gurbindo; G Lepage; M Godard; G E Rivard; E Seidman
Journal:  Am J Clin Nutr       Date:  1993-06       Impact factor: 7.045

View more
  2 in total

1.  Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.

Authors:  Patrícia Margarida Serra Carvalho; Nuno José Marques Mendes Silva; Patrícia Glória Dinis Dias; João Filipe Cordeiro Porto; Lèlita Conceição Santos; José Manuel Nascimento Costa
Journal:  J Diabetes Metab Disord       Date:  2013-06-06

2.  Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Authors:  Joanne A Hoogerland; Fabian Peeks; Brenda S Hijmans; Justina C Wolters; Sander Kooijman; Trijnie Bos; Aycha Bleeker; Theo H van Dijk; Henk Wolters; Albert Gerding; Karen van Eunen; Rick Havinga; Amanda C M Pronk; Patrick C N Rensen; Gilles Mithieux; Fabienne Rajas; Folkert Kuipers; Dirk-Jan Reijngoud; Terry G J Derks; Maaike H Oosterveer
Journal:  J Inherit Metab Dis       Date:  2021-04-07       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.